Ernexa Therapeutics Inc. (ERNA) Capital expenditures 2016–2025
Ernexa Therapeutics Inc. (ERNA) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$37,000FY2025 · since FY2016: $427,000 → $37,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $37,000 | -90.0% |
| FY2024 | $369,000 | +1842.1% |
| FY2023 | $19,000 | -93.6% |
| FY2022 | $297,000 | +92.9% |
| FY2021 | $154,000 | +294.9% |
| FY2020 | $39,000 | -69.5% |
| FY2019 | $128,000 | -80.2% |
| FY2018 | $648,000 | -11.0% |
| FY2017 | $728,000 | +70.5% |
| FY2016 | $427,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice